Search
Biohaven Ltd
BHVNAdd to Watchlist
13.570USD
-0.070-0.51%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.04BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
19
analysts
Buy
Current Rating
22.188
Target Price
+63.50%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Biohaven Ltd
BHVN
19
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Biohaven Ltd's expected revenue for the next quarter?
Biohaven Ltd's expected revenue is 394.17K.
What is Biohaven Ltd's price target?
Analysts forecast that Biohaven Ltd's price target is USD 49.50, with the highest forecast at USD 75.00 and the lowest forecast at USD 19.00.
How have Biohaven LtdBHVN's recent earnings per share performed?
The market expectation was USD -0.88, while Biohaven LtdBHVN's earnings per share (EPS) for the previous quarter was USD -1.21. EPS for the next quarter is expected at USD -0.72.
What is the analyst rating for Biohaven Ltd?
Based on the ratings of Biohaven Ltd's stock from 19 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
